Form 4: Korro Bio Officer Sells Shares for Tax Withholding

Korro Bio Chief Scientific Officer Vincent Loic A reports a mandatory sale of 3,418 common shares to cover tax obligations from a restricted stock unit vesting.

Summary

• Vincent Loic A, Chief Scientific Officer at Korro Bio, Inc., reported a transaction on June 16, 2026.
• The transaction involved the sale of 3,418 shares of common stock.
• This sale was mandatory to satisfy tax withholding obligations related to the vesting and settlement of a restricted stock unit (RSU) granted under the company's 2023 Stock Option and Incentive Plan.
• The shares were sold at a weighted-average price of $10.83, with individual sales ranging from $10.58 to $11.35.
• Following this transaction, Vincent Loic A beneficially owns 18,297 shares of common stock.
• This ownership includes an additional 10,858 shares issuable upon the settlement of another RSU that is scheduled to vest on December 15, 2026, contingent on continued service.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the share sale is a mandatory tax-related transaction and not indicative of a change in the reporting person's investment sentiment towards Korro Bio.

Positives

• The sale was a mandatory event to cover tax liabilities, indicating a standard process for equity compensation settlement.
• The reporting person retains a significant number of shares (18,297) after the transaction, including unvested RSUs.

Negatives

• A portion of the reporting person's equity was sold, reducing their direct holdings.

Risks

• The vesting of the remaining 10,858 RSUs on December 15, 2026, is contingent on the reporting person maintaining continuous service, introducing a risk of forfeiture if employment status changes.

Future Outlook

The filing indicates that 10,858 shares are expected to vest on December 15, 2026, subject to the reporting person's continued employment.

Industry Context

StockSavvy.ai notes that Form 4 filings are routine disclosures for corporate insiders, detailing changes in their beneficial ownership of company stock. This specific filing reflects a common practice of selling shares to cover tax liabilities arising from equity compensation, rather than an indication of a change in the insider's view of the company's prospects.

Stakeholder Impact

• Shareholders: No direct impact on share price is expected as this is a routine tax-related transaction by an insider. The overall beneficial ownership of the reporting person remains significant.
• Employees: Highlights the tax implications of equity compensation plans within the company.
• Management: Demonstrates adherence to SEC disclosure requirements regarding insider transactions.

Next Steps

• Monitoring the vesting of the remaining 10,858 RSUs on December 15, 2026.

Key Dates

Keywords

Korro Bio, KRRO, Form 4, Insider Trading, Stock Options, RSU, Tax Withholding, Beneficial Ownership, Vincent Loic A, Securities Exchange Act